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background:  The TRAPID-AMI study was a multicenter trial evaluating the high sensitivity cardiac troponin T (hs-cTnT) assay in a rapid 
“rule-out” acute myocardial infarction (AMI) strategy in the Emergency Department (ED). We evaluated a modified HEART score (HS) to 
identify a low-risk group that involves historical features, ECG findings, and normal hs-cTnT over 6 hours. Each element of the score is 
assigned a 0, 1, or 2 with a composite score ranging from 0-8.
methods:  There were 1,282 patients evaluated in the ED for possible AMI from 12 centers in Europe and the USA studied from 2011 to 
2013. Patients were enrolled if their onset of chest pain was < 6 hours prior to presentation, and hs-cTnT (99th %, 14 ng/L) was measured 
at presentation and 6 hours. The patients were followed for adverse events (AEs) at 30 days (death or AMI). Patients were considered low-
risk if they had hs-cTnT ≤ 14 ng/L at presentation and 6 hours, and had a modified HS ≤ 3.
Results:  There were 17 % (217/1282) of patients in the entire study that suffered an AE at 30 days: 8 deaths (0.6%) and 215 AMIs (17%). 
There were 40 % (514/1282) of patients that had normal serial hs-cTnT values and a modified HS ≤ 3. The AE rate in patients with a 
modified HS 3 was 0.2 % (1/514), and in those with a modified HS the AE rate was 1.8 % (5/285)(p=0.024).
conclusion:  Serial testing of hs-cTnT along with application of a modified HS may identify a very low-risk population with chest pain in the 
ED that might be able to be directly discharged without further observation and stress testing.
